Third-party Medical Diagnosis Market Size, Share, Competitive Landscape and Trend Analysis Report, by Application, by Service Types and, by End User : Opportunity Analysis and Industry Forecast, 2023-2032

Scope of the Study

The Third-party medical diagnosis market study provides a detailed analysis pertaining to the global market size & forecast, segmental splits, regional & country-level outlook, market dynamics & trends, Porters’ five force analysis, value chain analysis, competitive landscape, market share analysis, and patent analysis.

Segmental Outlook

The global Third-party medical diagnosis market is segmented depending on by application, by service types, by end user.

Segmental analysis is offered (real time and forecast) in both quantitative and qualitative terms. This helps the clients to identify the most lucrative segment to consider for their further investments, based on the comprehensive backend analysis about the segmental performance, in addition to brief understanding of the operating companies and their development activities with respect to the market.

Market Opportunities

Third-party medical diagnosis market is witnessing remunerative opportunities for expansion in the near future.

Graph for representation purpose only

Regional Outlook

The Third-party medical diagnosis market is analyzed across four key regions, which include North America, Europe, Asia-Pacific, and LAMEA. The key countries contributing toward the growth of the market include:

• North America: U.S., Canada, and Mexico

• Europe: Germany, UK, Italy, Spain, France, and rest of Europe

• Asia-Pacific: India, China, South Korea, Japan, Australia, and rest of Asia-Pacific

• LAMEA: Brazil, Saudi Arabia, South Africa, and rest of LAMEA

Key companies profiled in the report are Quest Diagnostics Incorporated, Roche Diagnostics, Hoffmann-La Roche (Roche), LabCorp, BioReference Laboratories Incorporation, BD, Eurofins Scientific, Quest Diagnostics, National Reference Laboratory, Myriad Genetics, Inc.

Third-party medical diagnosis market Attractiveness Index, By Region, 2024

Graph for representation purpose only

Competitive Scenario

The report profiles the top players operating across the globe along with market share analysis, and an outlook of top player positioning. In addition, the study focuses on the developmental strategies such as product launch, mergers & acquisitions, and collaborations adopted by the key players to maintain a competitive edge in the marketspace.

Report Coverage

• Growth projections: 2024 to 2032

• Major segments covering by application, by service types, by end user

• Market dynamics and trends

• Competitive landscape reporting

Research Methodology

AMR offers its clients with comprehensive research and analysis based on a wide variety of factual inputs that majorly include interviews with professionals in the industry, regional intelligence, and reliable statistics obtained from multiple resources. The in-house industry experts play an important role in designing analytic tools and models, tailored to the requirements of the client for a particular industry segment. These analytical tools and models refine the statistics & data and enhance the accuracy of our recommendations and advice.

  Third-party Medical Diagnosis Market Report Highlights

Aspects	Details
By Application	Pathology Radiology Dermatology Gene Testing Other Applications
By Service Types	Laboratory Services Consulting Services Equipment and Supplies Diagnosis Services Laboratory Information Systems Support and Maintenance Services Other Services
By End User	Research and Academic Institutes Clinics and Physician Offices Hospitals and Health Care Centers Other End Users
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Quest Diagnostics Incorporated, Myriad Genetics, LabCorp, Eurofins Scientific, BD, BioReference Laboratories Incorporation, National Reference Laboratory, Hoffmann-La Roche (Roche), Quest Diagnostics, Roche Diagnostics

^*Terms and Conditions Apply